Early multi-immune modulation with rilzabrutinib in patients with primary ITP after first-line treatment failure: A phase 3b study (LUNA 4)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: David Kuter, Waleed Ghanima, Nicola Cooper, Marie Luise Hütter-Krönke, Guillaume Moulis, Francesco Zaja, Maria Cristina Pascual Izquierdo, Howard Liebman, Sandhya Panch, Hisashi Kato, Matias Cordoba, Ahmed Daak, Maria Belen Rodriguez
Institutions: Harvard University, Massachusetts General Hospital, University of Oslo, Østfold Hospital Trust, Hammersmith Hospital, Humboldt-Universität zu Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, Centre Hospitalier Universitaire de Toulouse, University of Trieste, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, University of Southern California, University of Washington, Fred Hutch Cancer Center, Osaka University Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417013547
Cites:
Cited by:
Related to: